RPL5 and neoplasm: Other mouse models of RP haploinsuffciency are linked to tumor progression, such as uL5/RPL11 and eL22/RPL22 in mouse lymphoma development79,80 and uL18/RPL5 or eS24/RPS24 in mouse sarcomas81.